Latest statistics and disclosures from Vida Ventures Advisors's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PRAX, KNTE, KRON, DYN, ALLO, and represent 94.65% of Vida Ventures Advisors's stock portfolio.
- Added to shares of these 3 stocks: PRAX (+$162M), KNTE (+$109M), KRON (+$83M).
- Started 3 new stock positions in PRAX, KRON, KNTE.
- Vida Ventures Advisors was a net buyer of stock by $354M.
- Vida Ventures Advisors has $487M in assets under management (AUM), dropping by 205.18%.
- Central Index Key (CIK): 0001831423
Tip: Access up to 7 years of quarterly data
Positions held by Vida Ventures Advisors consolidated in one spreadsheet with up to 7 years of dataDownload as csv Download as Excel
Portfolio Holdings for Vida Ventures Advisors
Companies in the Vida Ventures Advisors portfolio as of the December 2020 quarterly 13F filing
|Company (Ticker)||Portfolio Weight||Valued At||Change in Shares||Share Count||Share Price|
|Praxis Precision Medicines Common Stock (PRAX)||33.2||$162M||NEW||2.9M||55.02|
|Kinnate Biopharma Common Stock (KNTE)||22.4||$109M||NEW||2.7M||39.78|
|Kronos Bio Common Stock (KRON)||17.0||$83M||NEW||2.8M||29.87|
|Dyne Therapeutics Common Stock (DYN)||12.8||$62M||3.0M||21.00|
|Allogene Therapeutics Common Stock (ALLO)||9.3||$45M||1.8M||25.24|
|Oyster Point Pharma Common Stock (OYST)||3.0||$15M||779k||18.82|
|Homology Medicines Common Stock (FIXX)||1.8||$8.7M||771k||11.29|
|Assembly Biosciences Common Stock (ASMB)||0.6||$2.7M||450k||6.05|